Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5384091, 9 pages
https://doi.org/10.1155/2017/5384091
Research Article

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

1Department of Clinical Laboratory Medicine, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
2Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, China
3The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area of Guangdong Higher Education Institutes, Shantou University Medical College, Shantou 515041, China
4Shantou University Medical College, Shantou 515041, China
5Department of Radiation Oncology, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
6Department of Oncological Research Laboratory, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
7Department of Surgical Oncology, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
8Institute of Oncologic Pathology, Shantou University Medical College, Shantou 515041, China

Correspondence should be addressed to Yu-Hui Peng; moc.361@666iuhuygnep and En-Min Li; nc.ude.uts@ilmn

Received 9 May 2017; Revised 10 July 2017; Accepted 16 July 2017; Published 9 August 2017

Academic Editor: Stamatios E. Theocharis

Copyright © 2017 Yi-Wei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yi-Wei Xu, Can-Tong Liu, Xin-Yi Huang, et al., “Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma,” Disease Markers, vol. 2017, Article ID 5384091, 9 pages, 2017. https://doi.org/10.1155/2017/5384091.